The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Radiofrequency renal denervation is effective – and safe?

EuroIntervention 2020;16:21-23. DOI: 10.4244/EIJV16I1A4

1. Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University, Homburg/Saar, Germany; 2. Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA


Hypertension remains a major contributor to cardiovascular morbidity and mortality with increasing prevalence worldwide1. Despite the availability of several effective pharmacological treatment options, control of high blood pressure (BP) to target values remains challenging in many patients. Catheter-based renal denervation (RDN) is a treatment modality which targets renal sympathetic activity, a crucial component of the pathophysiology of uncontrolled hypertension2. With the publication of several recent randomised, sham-controlled trials3,4,5,6,7, the proof of principle for the blood pressure-lowering efficacy of radiofrequency and ultrasound RDN has been provided. In these studies, treatment with RDN when compared with sham was associated with larger ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Why stronger radiation safety measures are essential for the modern workforce. A perspective from EAPCI Women and Women as One